United Therapeutics Corporation (UTHR)

USD 357.55

(-5.83%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 7.16 Billion 6.04 Billion 5.16 Billion 4.61 Billion 3.91 Billion 3.4 Billion
Total Current Assets 3.55 Billion 3.38 Billion 2.32 Billion 2.16 Billion 1.86 Billion 1.76 Billion
Cash And Short Term Investments 2.99 Billion 4.15 Billion 3.58 Billion 2.98 Billion 2.25 Billion 1.85 Billion
Cash and Cash Equivalents 1.2 Billion 961.2 Million 894.8 Million 738.7 Million 738.4 Million 669.2 Million
Short Term Investments 1.78 Billion 1.87 Billion 1.03 Billion 1.09 Billion 747.5 Million 746.7 Million
Net Receivables 278.9 Million 220.4 Million 198.7 Million 157.4 Million 151.4 Million 175.7 Million
Inventory 111.8 Million 102 Million 93.8 Million 86.5 Million 93.4 Million 101 Million
Other Current Assets 166.2 Million 219.2 Million 100.4 Million 88.3 Million 133.8 Million 75.4 Million
Total Non-Current Assets 3.61 Billion 2.66 Billion 2.84 Billion 2.44 Billion 2.04 Billion 1.63 Billion
Net PPE 1.04 Billion 861.5 Million 780.9 Million 731.6 Million 738.5 Million 699.7 Million
Good Will And Intangible Assets 114.2 Million 44.5 Million 44.6 Million 158.1 Million 158.3 Million 170.8 Million
Good Will 33.7 Million 28 Million 28 Million 28 Million 28 Million 31.5 Million
Intangible Assets 80.5 Million 16.5 Million 16.6 Million 130.1 Million 130.3 Million 139.3 Million
Long-Term Investments 1.9 Billion 1.31 Billion 1.64 Billion 1.14 Billion 767.5 Million 442.6 Million
Tax Assets 394.8 Million 327.7 Million 261.9 Million 238.6 Million 230 Million 95.7 Million
Other Non Current Assets 151.8 Million 114.3 Million 108.2 Million 169.9 Million 154.6 Million 224.2 Million
Other Assets - - - - - -
Total Liabilities 1.18 Billion 1.24 Billion 1.21 Billion 1.21 Billion 1.13 Billion 612.4 Million
Total Current Liabilities 804.4 Million 343.2 Million 305.4 Million 323.3 Million 463 Million 276.6 Million
Account Payables 5.6 Million 4.1 Million 3.8 Million 4.1 Million 9.9 Million 23.1 Million
Tax Payables - - - - - -
Short Term Debt 400 Million - - - 250 Million -
Deferred Revenue 327.8 Million - - - 163.5 Million -
Other Current Liabilities 71 Million 339.1 Million 301.6 Million 319.2 Million 39.6 Million 253.5 Million
Total Non Current Liabilities 377.8 Million 904.6 Million 904.8 Million 896.5 Million 670 Million 316.6 Million
Long-Term Debt 300 Million 800 Million 800 Million 800 Million 600 Million 250 Million
Deferred Revenue Non Current -42.4 Million -41 Million -30 Million -27.4 Million -45.5 Million -53.3 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 77.8 Million 104.6 Million 104.8 Million 96.5 Million 70 Million 66.6 Million
Other Liabilities - - - - - 19.2 Million
Total Equity 5.98 Billion 4.79 Billion 3.95 Billion 3.39 Billion 2.78 Billion 2.78 Billion
Stock Holders Equity 5.98 Billion 4.79 Billion 3.95 Billion 3.39 Billion 2.78 Billion 2.78 Billion
Common Stock 700 Thousand 700 Thousand 700 Thousand 700 Thousand 700 Thousand 700 Thousand
Retained Earnings 6.02 Billion 5.04 Billion 4.31 Billion 3.83 Billion 3.32 Billion 3.43 Billion
Accumulated other comprehensive income -12.8 Million -55.5 Million -23 Million -14.2 Million -14.2 Million -7.9 Million
Common Stock Equity 5.98 Billion 4.79 Billion 3.95 Billion 3.39 Billion 2.78 Billion 2.78 Billion
Capital Lease Obligation 32.8 Million - - - 3 Million -
Total Investments 3.69 Billion 3.19 Billion 2.68 Billion 2.24 Billion 1.51 Billion 1.18 Billion
Total Debt 700 Million 800 Million 800 Million 800 Million 850 Million 250 Million
Net Debt -507.7 Million -161.2 Million -94.8 Million 61.3 Million 111.6 Million -419.2 Million

Balance Sheet Charts